Bedford, MA, United States of America

Chintan Patel

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Ocular Therapeutix, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chintan Patel. Retrieved from https://idiyas.com/inventor/chintan-patel-h5lwyh2r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Ocular Treatment by Chintan Patel

Introduction

Chintan Patel is an innovative inventor based in Bedford, MA, who has made significant contributions to the field of ocular medicine. His work focuses on developing advanced treatments for retinal diseases, showcasing his commitment to improving patient outcomes through innovative solutions.

Latest Patents

Chintan Patel holds a patent for an ocular implant containing a tyrosine kinase inhibitor. This invention relates to a sustained release biodegradable ocular implant that contains axitinib dispersed in a hydrogel. It is designed for the treatment of retinal diseases over an extended period of time, representing a significant advancement in ocular therapy.

Career Highlights

Chintan Patel is currently associated with Ocular Therapeutix, Inc., where he applies his expertise in developing cutting-edge ocular treatments. His work at the company emphasizes the importance of innovation in addressing complex medical challenges.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Chintan Patel's contributions to ocular medicine through his innovative patent highlight the potential for advancements in treating retinal diseases. His work exemplifies the impact of dedicated inventors in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…